The Venture Codex Logo

The Venture Codex

Yonjin Capital

125 Cambridge Park Drive, Suite 301, Cambridge, MA, 02140, United States

Overview

Investment firm specializing in early and mid-stage life science companies.

Founded

2016

Deals ยท 12mo

0

Links

Website

Stage focus

Series A
Series B

Geographic focus

Belgium
China
Israel
United States

Sector focus

Health Diagnostics
Medical Device
Therapeutics
Venture Capital

Investment portfolio

19rounds
NAMEDATESIZE
Rapafusyn Pharmaceuticals
Sep 2025Participated
$44 MSeries A
TECLens
Feb 2025Led
$9 MSeries A
CSA Medical
Sep 2024Led
$53 MSeries D
HistoSonics
Aug 2024Participated
$102 MSeries D
Spear Bio
Jul 2024Participated
$45 MSeries A
EvolveImmune Therapeutics
Dec 2023Participated
$37 MOther Equity
HistoSonics
Dec 2022Participated
$100 MOther Equity
Intressa Vascular
Oct 2022Participated
$12 MOther Equity
Regenacy Pharmaceuticals
Aug 2022Participated
$9 MSeries B
Bluejay Therapeutics
Aug 2022Participated
$41 MSeries B
ITabMed
Dec 2021Led
$20 MSeries A
OncoResponse
Mar 2021Participated
$41 MSeries C
Rapafusyn Pharmaceuticals
Sep 2025Participated
$44 MSeries A
TECLens
Feb 2025Led
$9 MSeries A
CSA Medical
Sep 2024Led
$53 MSeries D
HistoSonics
Aug 2024Participated
$102 MSeries D
Spear Bio
Jul 2024Participated
$45 MSeries A
EvolveImmune Therapeutics
Dec 2023Participated
$37 MOther Equity
HistoSonics
Dec 2022Participated
$100 MOther Equity
Intressa Vascular
Oct 2022Participated
$12 MOther Equity
Regenacy Pharmaceuticals
Aug 2022Participated
$9 MSeries B
Bluejay Therapeutics
Aug 2022Participated
$41 MSeries B
ITabMed
Dec 2021Led
$20 MSeries A
OncoResponse
Mar 2021Participated
$41 MSeries C
19
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Yonjin Capital: 19 funding rounds are recorded in the selected participation categories.All available history.
Yonjin Capital: 19 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A24
Series B06
Series C+22
Other Equity03

Monthly Deal Activity

Yonjin Capital: 19 deals are recorded across 94 months.All available history.
Yonjin Capital: 19 deals are recorded across 94 months. All available history
MonthDeals
Jan '191
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '201
Apr '200
May '200
Jun '203
Jul '200
Aug '200
Sep '201
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '212
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '211
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '222
Sep '220
Oct '221
Nov '220
Dec '221
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '231
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '241
Aug '241
Sep '241
Oct '240
Nov '240
Dec '240
Jan '250
Feb '251
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '251
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Yonjin Capital: Health & Life Sciences is the largest displayed sector by deal count (19 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Yonjin Capital: Health & Life Sciences is the largest displayed sector by deal count (19 deals). All available history
SectorDeals
Health & Life Sciences19
Networks, Cloud & Communication2

Deal Size Distribution

Yonjin Capital: 19 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Yonjin Capital: 19 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M3
$10M-$25M2
$25M-$50M9
$50M-$100M1
$100M-$250M4
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Yonjin Capital: United States has the largest recorded deal count among the displayed regions (16 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

Yonjin Capital: United States has the largest recorded deal count among the displayed regions (16 deals). All available history
RegionDeals
United States16
Europe1
Israel1
China1
Yonjin Capital: 20 co-investors are shown, with 3E Bioventures Capital sharing 5 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Yonjin Capital: 20 co-investors are shown, with 3E Bioventures Capital sharing 5 recorded deals. All available history
Co-investorShared deals
3E Bioventures Capital5
Cobro Ventures5
Johnson & Johnson Innovation5
Taiwania Capital4
Axil Capital3
Lumira Ventures3
State of Wisconsin Investment Board3
Venture Investors3
RiverVest Venture Partners2
3B Future Health Fund1
Adage Capital Management1
Alexandria Venture Investments1
Ally Bridge Group1
Alpha Wave Ventures1
Amzak Health1
ARCH Venture Partners1
Arkin Bio Ventures1
Ascension Ventures1
Bain Capital Life Sciences1
Bering Capital1

Investment Strategy

Yonjin Capital: Led accounts for 21% and participating for 79% of round participation.All available history.
Yonjin Capital: Led accounts for 21% and participating for 79% of round participation. All available history
CategoryDeals (count)Share (%)
Led421%
Participating1579%
Yonjin Capital: Single-lead accounts for 25% and co-led for 75% of lead dynamics.All available history.
Yonjin Capital: Single-lead accounts for 25% and co-led for 75% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead125%
Co-led375%

Team

Chong Wang

Executive Director

Daguan Wang

Managing Director

Fanbo Meng

Executive Director

Gary Yang

Partner

Qiong Ye

Vice President

Shirley Xu

Executive Director

Tina Huang

Partner

Wen Chen

Venture Partner